Are there differences between macrocyclic gadolinium contrast agents for brain tumor imaging? Results of a multicenter intraindividual crossover comparison of gadobutrol with gadoteridol (the TRUTH study).

BACKGROUND AND PURPOSE: Gadobutrol (Gadavist) and gadoteridol (ProHance) have similar macrocyclic molecular structures, but gadobutrol is formulated at a 2-fold higher (1 mol/L versus 0.5 mol/L) concentration. We sought to determine whether this difference impacts morphologic contrast-enhanced MR imaging. MATERIALS AND METHODS: Two hundred twenty-nine adult patients with suspected or known brain tumors underwent two 1.5T MR imaging examinations with gadoteridol or gadobutrol administered in randomized order at a dose of 0.1 mmol/kg of body weight. Imaging sequences and T1 postinjection timing were identical for both examinations. Three blinded readers evaluated images qualitatively and quantitatively for lesion detection and for accuracy in characterization of histologically confirmed brain tumors. Data were analyzed by using the Wilcoxon signed rank test, the McNemar test, and a mixed model. RESULTS: Two hundred nine patients successfully completed both examinations. No reader noted a significant qualitative or quantitative difference in lesion enhancement, extent, delineation, or internal morphology (P values = .69-1.00). One hundred thirty-nine patients had at least 1 histologically confirmed brain lesion. Two readers found no difference in the detection of patients with lesions (133/139 versus 135/139, P = .317; 137/139 versus 136/139, P = .564), while 1 reader found minimal differences in favor of gadoteridol (136/139 versus 132/139, P = .046). Similar findings were noted for the number of lesions detected and characterization of tumors (malignant/benign). Three-reader agreement for characterization was similar for gadobutrol (66.4% [κ = 0.43]) versus gadoteridol (70.3% [κ = 0.45]). There were no significant differences in the incidence of adverse events (P = .199). CONCLUSIONS: Gadoteridol and gadobutrol at 0.1 mmol/kg of body weight provide similar information for visualization and diagnosis of brain lesions. The 2-fold higher gadolinium concentration of gadobutrol provides no benefit for routine morphologic imaging.

Shape of the human corpus callosum. Elliptic Fourier analysis on midsagittal magnetic resonance scans.

RATIONALE AND OBJECTIVES: Sex, age, or functional-asymmetry-related variations in the size and shape characteristics of the midsagittal magnetic resonance (MR) image of the human corpus callosum (CC) have been widely investigated in the last 10 years, with conflicting results. In the current study, the authors attempted to analyze the sex- and age-related shape differences of the human CC in a large sample of adult subjects from a mathematical standpoint. METHODS: On the midsagittal MR images of 143 neurologically intact adults (75 women, 68 men, 21 to 81 years of age) the outline of the CC was identified. The shape of the CC was quantified using elliptic Fourier analysis, which allows for a global evaluation of the shape of organs identified by their outlines independent of their size, spatial orientation, and relation to reference planes. Subjects were grouped by sex and age. RESULTS: The shape of the human CC within age and sex class was highly variable. The analysis of variance showed a significant effect of age; however no significant sex differences could be demonstrated. CONCLUSIONS: Larger sample sizes are required to definitively assess the normal shape variations in human CC. The method developed also could be applied to the comparison of healthy and diseased individuals.

Shape of the human corpus callosum in childhood. Elliptic Fourier analysis on midsagittal magnetic resonance scans.

RATIONALE AND OBJECTIVES: The authors previously investigated the midsagittal magnetic resonance images of neurologically intact adults, and analyzed the shape of corpus callosum from a mathematic standpoint. Significant effects of age were demonstrated, without significant sex differences. In the current study, the same mathematic method was applied to analyze the sex and age shape differences of the human corpus callosum in childhood. METHODS: On the midsagittal magnetic resonance images of 84 neurologically intact children (39 boys, 45 girls, aged 4 months to 15 years) the outline of the corpus callosum was identified. Its shape was quantified using elliptic Fourier analysis, which allows for global evaluation of the shape of organs identified by their outlines independently from size, spatial orientation, and relationship to reference planes. Subjects were grouped by sex and age. RESULTS: The shape of the corpus callosum within age and sex classes in childhood was more homogeneous than in adulthood. A significant effect of age was demonstrated by the analysis of variance; however, no significant sex differences were found. CONCLUSIONS: Corpus callosum shape in midsagittal magnetic resonance images was strongly influenced by central nervous system development and aging, but the influence of sex was not sufficient to be detected by current standard magnetic resonance imaging technology, and by the available sample sizes. The current investigation supplies data on the normal callosal shape in the first two decades of life, thus completing previous analysis.

Isolated noncompaction of the ventricular myocardium. A study in an adult male and literature review.

Noncompaction of the ventricular myocardium is a rare congenital disorder characterized by the presence of numerous prominent trabeculations and deep intertrabecular recesses which communicate with the left ventricular cavity. The disease uniformly affects the left ventricle, sometimes also affecting the right ventricle. Noncompaction of the ventricular myocardium is believed to be a disorder of endomyocardial embryogenesis. Familial occurrence has been observed. It may be accompanied by depressed ventricular function, cardiac arrhythmia and systemic embolism. Although noncompaction of the ventricular myocardium is a congenital myocardial disorder, the onset of symptoms is frequently delayed until adulthood. We describe a case of noncompaction of the ventricular myocardium in a 33-year-old male with the typical echocardiographic and cardiac magnetic resonance imaging features of this disease.